Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Edwards

Showing results (271-280 of 309) with videos related to

Pageof 31
Sort By:
Gynecologic Oncology|September 18, 2022
Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancerJune Y Hou, Jocelyn S Chapman, Ekaterina Kalashnikova, et al.
Cell Reports|April 6, 2022
Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancerSohail Jahid, Jose A Ortega, Linh M Vuong, et al.
The New England Journal of Medicine|April 17, 2019
Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyVlado Perkovic, Meg J Jardine, Bruce Neal, et al.
Cell Reports|April 27, 2022
Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancerSohail Jahid, Jose A Ortega, Linh M Vuong, et al.
Circulation|July 12, 2019
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention GroupsKenneth W Mahaffey, Meg J Jardine, Severine Bompoint, et al.
Nature Biotechnology|May 26, 2015
Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targetingHuanhuan Joyce Chen, Jian Sun, Zhiliang Huang, et al.
Antimicrobial Resistance and Infection Control|November 23, 2021
Infection prevention strategies are highly protective in COVID-19 units while main risks to healthcare professionals come from coworkers and the communityShruti K Gohil, Kathleen A Quan, Keith M Madey, et al.
Nature Reviews. Neurology|June 17, 2020
Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunitiesKaren D Davis, Nima Aghaeepour, Andrew H Ahn, et al.
The ISME Journal|February 12, 2010
Viral and microbial community dynamics in four aquatic environmentsBeltran Rodriguez-Brito, Linlin Li, Linda Wegley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2013
Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortiumMartin Köbel, Steve E Kalloger, Sandra Lee, et al.
Pageof 31

Showing results (271-280 of 309) with videos related to

Sort By:
Pageof 31
Gynecologic Oncology|September 18, 2022
Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancerJune Y Hou, Jocelyn S Chapman, Ekaterina Kalashnikova, et al.
Cell Reports|April 6, 2022
Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancerSohail Jahid, Jose A Ortega, Linh M Vuong, et al.
The New England Journal of Medicine|April 17, 2019
Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyVlado Perkovic, Meg J Jardine, Bruce Neal, et al.
Cell Reports|April 27, 2022
Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancerSohail Jahid, Jose A Ortega, Linh M Vuong, et al.
Circulation|July 12, 2019
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention GroupsKenneth W Mahaffey, Meg J Jardine, Severine Bompoint, et al.
Nature Biotechnology|May 26, 2015
Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targetingHuanhuan Joyce Chen, Jian Sun, Zhiliang Huang, et al.
Antimicrobial Resistance and Infection Control|November 23, 2021
Infection prevention strategies are highly protective in COVID-19 units while main risks to healthcare professionals come from coworkers and the communityShruti K Gohil, Kathleen A Quan, Keith M Madey, et al.
Nature Reviews. Neurology|June 17, 2020
Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunitiesKaren D Davis, Nima Aghaeepour, Andrew H Ahn, et al.
The ISME Journal|February 12, 2010
Viral and microbial community dynamics in four aquatic environmentsBeltran Rodriguez-Brito, Linlin Li, Linda Wegley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2013
Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortiumMartin Köbel, Steve E Kalloger, Sandra Lee, et al.
Pageof 31